| CASE REPORT |
|
| Year : 2021 | Volume
: 13
| Issue : 1 | Page : 42-43 |
|
|
Positive SARS-CoV-2 RNA with significant inflammatory state and thrombophilia after 12 weeks of initial diagnosis of COVID-19 infection
Manuel Francisco Betancourt1, Kimberly Michelle Grant1, James Scott Johnson1, Dhanashree S Kelkar2, Kamal Sharma3
1 Department of Critical Care Medicine, BayCare Winter Haven Hospital, Jacksonville, Florida, USA
2 Department of Emergency Medicine, University of Florida, Jacksonville, Florida, USA
3 Department of Hematology, BayCare Winter Haven Hospital, Jacksonville, Florida, USA
Correspondence Address:
Dr. Manuel Francisco Betancourt
Department of Critical Care Medicine, BayCare Winter Haven Hospital, Florida
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jgid.jgid_286_20
|
|
|
The ongoing COVID-19 pandemic has affected most countries in the world, with significant economic and public health implications. There is rising concern that patients who recover from COVID-19 may be at risk of reinfection. Another potential concern is the uncommon clinical scenario of a patient having persistent SARS-CoV-2 RNA test over 3 months after the initial COVID-19 infection, as the patient presented. Whether presenting as a long-term infection (12 weeks) or reinfection, patients with COVID-19 will continue to have a severe inflammatory and prothrombotic state that could carry potential life-threatening thrombosis. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
